COVID-19 has dominated our lives for two years now. Although we are returning to a new normal, with the help of rapidly developed vaccines, do we truly understand the...

Through its issuance of recommendations and regulatory decisions concerning medical products, the US Food and Drug Administration (FDA) typically considers the “unmet...

As the world continues to adapt to the impact of the pandemic, a legacy has seen the evolvement of varying approaches to how clinical trials are designed and deployed...

Each year, on the 20th of May, the global health community celebrates International Clinical Trials Day, the anniversary of James Lind’s famous scurvy experiment in 1...

Sample size has always been one of the first design choices a medical device sponsor has to make for a clinical study. But the calculation of sample size is not the m...

Stakeholders across the life sciences industry now understand that data is more important than documents but also that it’s crucial that the data is reliable and can ...

The successful execution of international clinical trials requires the involvement of service providers adhering to a wide range of regulatory guidelines and industry...

The subject of Regenerative Medicine is currently at an inflexion point. There has been an enormous amount of financial investment, along with basic and clinical rese...

Epilepsy is one of the most common and disabling chronic neurologic disorders that affects more than 50 million people worldwide. Despite the current of over two doze...

Acute Myeloid Leukaemia (AML) is a blood cancer characterised by the overproduction of immature white blood cells in the bone marrow. These proliferating immature cel...